Surgery Partners, Inc. (SGRY) financial statements (2021 and earlier)

Company profile

Business Address 310 SEVEN SPRINGS WAY
BRENTWOOD, TN 37027
State of Incorp. DE
Fiscal Year End December 31
SIC 8062 - General Medical and Surgical Hospitals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments31845032619593111117
Cash and cash equivalents31845032619593111117
Receivables382337311312327303302
Inventory, net of allowances, customer advances and progress billings56514949464444
Inventory56514949464444
Prepaid expense181923 18  
Other current assets273637 42  
Other undisclosed current assets   59 5966
Total current assets:802893747615526518529
Noncurrent Assets
Finance lease, right-of-use asset258   237147146
Operating lease, right-of-use asset310315312293   
Property, plant and equipment (171)(152)(130) (98)(75)
Long-term investments and receivables90929191939393
Long-term investments90929191939393
Intangible assets, net (including goodwill), including:3,5153,3893,4553,4433,4503,4583,456
Goodwill3,4683,3453,4093,3973,4023,4063,402
Intangible assets, net (excluding goodwill)47   475354
Other undisclosed intangible assets, net (including goodwill) 454647   
Restricted cash and investments0000000
Estimated insurance recoveries11121212121212
Deferred income tax assets12510611511499  
Other noncurrent assets27202221329344313
Other undisclosed noncurrent assets276656644632274443416
Total noncurrent assets:4,6124,4204,4984,4764,4934,4004,362
TOTAL ASSETS:5,4135,3135,2455,0915,0194,9184,891
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities166156163148151131118
Accounts payable10090105107978572
Employee-related liabilities65665841544646
Debt64616460565157
Other liabilities217233220203191199194
Other undisclosed current liabilities110141125    
Total current liabilities:557591571412398382369
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,7922,7612,6232,6272,5252,4032,397
Finance lease, liability262   238140136
Operating lease, liability301306299279283281255
Other undisclosed long-term debt and lease obligation2,2292,4552,3242,3472,0041,9822,006
Liabilities, other than long-term debt201190196206397426387
Other liabilities140125127130397426387
Derivative instruments and hedges, liabilities61656976   
Other undisclosed noncurrent liabilities240241230203   
Total noncurrent liabilities:3,2333,1923,0493,0362,9212,8292,785
Total liabilities:3,7903,7833,6203,4473,3203,2113,153
Temporary equity, carrying amount741729729720716700693
Stockholders' equity
Stockholders' equity attributable to parent, including:116101204237297329359
Additional paid in capital608  655663670678
Accumulated other comprehensive loss(61)  (76)(51)(58)(51)
Accumulated deficit(432)  (343)(316)(285)(269)
Other undisclosed stockholders' equity attributable to parent11012041111
Stockholders' equity attributable to noncontrolling interest767700692687687678686
Total stockholders' equity:8828018969239831,0071,045
TOTAL LIABILITIES AND EQUITY:5,4135,3135,2455,0915,0194,9184,891

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues548496375441517452445
Cost of revenue    (388)(353)(340)
Gross profit:54849637544112999105
Operating expenses(452)(478)(330)(418)1,034(393)(390)
Other operating income, net
(Other Nonrecurring (Income) Expense)
    1  
Other undisclosed operating income (loss)    (1,093)353340
Operating income:96194524725956
Interest and debt expense(7)   (1)(11)(7)
Income from continuing operations before equity method investments, income taxes:90194524714848
Income from equity method investments333    
Income from continuing operations before income taxes:93224724714848
Income tax expense (benefit)6(1)115(4)(2)(1)
Income before gain (loss) on sale of properties:99204839664647
Other undisclosed net loss(51)(55)(52)(47)(44)(35)(39)
Net income (loss):48(34)(4)(8)23118
Net loss attributable to noncontrolling interest(42)(27)(29)(19)(42)(27)(28)
Net income (loss) attributable to parent:6(62)(33)(28)(19)(16)(20)
Undistributed earnings (loss) allocated to participating securities, basic(10)(10)(10)(10)(9)(9)(9)
Net loss available to common stockholders, diluted:(5)(72)(42)(37)(29)(25)(29)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):48(34)(4)(8)23118
Other undisclosed comprehensive income (loss)437(25)7(7)(17)
Comprehensive income (loss):52(31)3(34)294(9)
Comprehensive loss, net of tax, attributable to noncontrolling interest(42)(27)(29)(19)(42)(27)(28)
Comprehensive income (loss), net of tax, attributable to parent:10(58)(25)(53)(12)(23)(37)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: